Skip to Content

Gadofosveset trisodium Pregnancy and Breastfeeding Warnings

Gadofosveset trisodium is also known as: Ablavar, Vasovist

Gadofosveset trisodium Pregnancy Warnings

Gadofosveset trisodium has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of teratogenicity. There are no controlled data in human pregnancy. Gadofosveset trisodium is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.

See references

Gadofosveset trisodium Breastfeeding Warnings

There are no data on the excretion of gadofosveset trisodium into human milk. The effects in the nursing infant are unknown. The manufacturer recommends that caution be used when administering gadofosveset trisodium to nursing women.

See references

References for pregnancy information

  1. "Product Information. Vasovist (gadofosveset trisodium)." Bayer Pharmaceutical Inc, West Haven, CT.

References for breastfeeding information

  1. "Product Information. Vasovist (gadofosveset trisodium)." Bayer Pharmaceutical Inc, West Haven, CT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide